Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction Adenocarcinoma
Clinical trial NCT06163729 · RECRUITING
Trial details
- NCT number
- NCT06163729
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-25
- Primary completion
- 2025-05-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.